for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ortho Clinical Diagnostics tumbles nearly 9% in Nasdaq debut

Jan 28 (Reuters) - Shares of private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics fell 8.8% in their Nasdaq debut on Thursday, giving the Raritan, New Jersey-based diagnostics company a market capitalization of $3.36 billion.

Reporting by Amruta Khandekar in Bengaluru; Editing by Vinay Dwivedi

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up